RSVIVAX Trademark

Trademark Overview

On Friday, October 7, 2016, a trademark application was filed for RSVIVAX with the United States Patent and Trademark Office. The USPTO has given the RSVIVAX trademark a serial number of 87196123. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 30, 2019. This trademark is owned by Novavax, Inc.. The RSVIVAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses

Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines
rsvivax

General Information

Serial Number87196123
Word MarkRSVIVAX
Filing DateFriday, October 7, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 30, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesVaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine adjuvants to prevent respiratory syncytial virus (RSV) and other respiratory illnesses
Goods and ServicesPharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 13, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 13, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, December 30, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 30, 2019ABANDONMENT - NO USE STATEMENT FILED
Monday, October 14, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 14, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 24, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2019EXTENSION 4 GRANTED
Wednesday, April 10, 2019EXTENSION 4 FILED
Wednesday, April 10, 2019TEAS EXTENSION RECEIVED
Friday, October 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 10, 2018EXTENSION 3 GRANTED
Wednesday, October 10, 2018EXTENSION 3 FILED
Wednesday, October 10, 2018TEAS EXTENSION RECEIVED
Thursday, May 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 22, 2018EXTENSION 2 GRANTED
Tuesday, May 22, 2018EXTENSION 2 FILED
Tuesday, May 22, 2018TEAS EXTENSION RECEIVED
Thursday, October 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 17, 2017EXTENSION 1 GRANTED
Tuesday, October 17, 2017EXTENSION 1 FILED
Tuesday, October 17, 2017TEAS EXTENSION RECEIVED
Tuesday, May 23, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 16, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, February 16, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 16, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, February 16, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 14, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, February 7, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Sunday, January 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2017ASSIGNED TO EXAMINER
Monday, December 12, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, December 12, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 11, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

rsvivax respiratory vaccine research biologic vaccines syncytial field pharmaceutical development adjuvants